These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7205594)

  • 1. Quantitation of the antineoplastic agent indicine-N-oxide in human plasma by differential pulse polarography.
    McComish M; Bodek I; Branfman AR
    J Pharm Sci; 1980 Jun; 69(6):727-9. PubMed ID: 7205594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-Oxide reduction by hemoglobin, cytochrome C and ferrous ions.
    Powis G; DeGraw CL
    Res Commun Chem Pathol Pharmacol; 1980 Oct; 30(1):143-50. PubMed ID: 6254119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic conversion of indicine N-oxide to indicine in rabbits and humans.
    Powis G; Ames MM; Kovach JS
    Cancer Res; 1979 Sep; 39(9):3564-70. PubMed ID: 476682
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determination of indicine N-oxide and indicine in plasma and urine by electron-capture gas-liquid chromatography.
    Ames MM; Powis G
    J Chromatogr; 1978 Dec; 166(2):519-26. PubMed ID: 748361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic study of indicine N-oxide in pediatric cancer patients.
    Ames MM; Miser JS; Smithson WA; Coccia PF; Hughes CS; Davis DM
    Cancer Chemother Pharmacol; 1982 Dec; 10(1):43-6. PubMed ID: 7160044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship of the reductive metabolism of indicine N-oxide to its antitumor activity.
    Powis G; Ames MM; Kovach JS
    Res Commun Chem Pathol Pharmacol; 1979 Jun; 24(3):559-69. PubMed ID: 451340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stability-indicating colorimetric assay for indicine N-oxide using TLC.
    D'Silva JB; Notari RE
    J Pharm Sci; 1980 Apr; 69(4):471-2. PubMed ID: 7373551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The gas chromatographic mass spectrometric analysis of the new antitumor drug indicine-N-oxide utilizing a novel reaction accompanying trimethylsilylation.
    Evans JV; Peng A; Nielsen CJ
    Biomed Mass Spectrom; 1979 Jan; 6(1):38-43. PubMed ID: 427260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct quantitative analysis of indicine-N-oxide in cancer patient samples by gas chromatography using the internal standard heliotrine-N-oxide including a mass spectral comparison of their trimethylsilyl derivatives.
    Evans JV; Daley SK; McClusky GA; Nielsen CJ
    Biomed Mass Spectrom; 1980 Feb; 7(2):65-73. PubMed ID: 7407334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyridine nucleotide cofactor requirements of indicine N-oxide reduction by hepatic microsomal cytochrome P-450.
    Powis G; Wincentsen L
    Biochem Pharmacol; 1980 Feb; 29(3):347-51. PubMed ID: 6767485
    [No Abstract]   [Full Text] [Related]  

  • 11. Determination of flucytosine in tablets by differential pulse polarography.
    Teare FW; Yadav RN; Spino M
    J Pharm Sci; 1978 Nov; 67(11):1641-2. PubMed ID: 712613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determination of nitroimidazoles in biological fluids by differential pulse polarography.
    Brooks MA; D'Arconte L; de Silva JA
    J Pharm Sci; 1976 Jan; 65(1):112-4. PubMed ID: 1255413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indicine-N-oxide: a new antitumor agent.
    Poster DS; Bruno S; Penta J; Macdonald JS
    Cancer Treat Rep; 1981; 65(1-2):53-6. PubMed ID: 6939484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron-EDTA stimulated reduction of indicine N-oxide by the hepatic microsomal fraction, isolated hepatocytes, and the intact rat.
    Powis G; Svingen BA; Degraw C
    Biochem Pharmacol; 1982 Feb; 31(3):293-9. PubMed ID: 6280724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disposition of indicine N-oxide in mice and monkeys.
    El Dareer SM; Tillery KF; Lloyd HH; Hill DL
    Cancer Treat Rep; 1982 Jan; 66(1):183-6. PubMed ID: 7053256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic failure secondary to indicine N-oxide toxicity. A Pediatric Oncology Group Study.
    Cook BA; Sinnhuber JR; Thomas PJ; Olson TA; Silverman TA; Jones R; Whitehead VM; Ruymann FB
    Cancer; 1983 Jul; 52(1):61-3. PubMed ID: 6573942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Indicine N-oxide: clinical use of a pyrrolizidine alkaloid.
    King SA; Suffness M; Leyland-Jones B; Hoth DF; O'Dwyer PJ
    Cancer Treat Rep; 1987 May; 71(5):517-23. PubMed ID: 3552221
    [No Abstract]   [Full Text] [Related]  

  • 18. A simple differential pulse polarographic method for the determination of thymoquinone in black seed oil.
    Michelitsch A; Rittmannsberger A
    Phytochem Anal; 2003; 14(4):224-7. PubMed ID: 12892418
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the antimalaria drug artemether in pharmaceutical preparations by differential pulse polarography.
    Debnath C; Haslinger E; Likussar W; Michelitsch A
    J Pharm Biomed Anal; 2006 May; 41(2):638-43. PubMed ID: 16413733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular toxicity during the treatment of refractory acute leukemia with indicine N-oxide.
    Letendre L; Ludwig J; Perrault J; Smithson WA; Kovach JS
    Cancer; 1984 Oct; 54(7):1256-9. PubMed ID: 6590115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.